About us
Pricing
Contact
Subscribe
Journals
Articles
Research Areas
Publishers
Trends
World Map
Compare
Site Map
M
Massimo Cristofanilli
The University of Texas MD Anderson Cancer Center
ORCID https://orcid.org/0000-0002-4194-7175
h-index
—
Publications
—
Citations
—
i10-index
—
Impact (2-yr)
—
Top Publications
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
Journal of Clinical Oncology
2008
2,876 citations
Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy
Clinical Cancer Research
2005
1,881 citations
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
The Lancet Oncology
2016
1,795 citations
First author
Corresponding
Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System
Clinical Cancer Research
2007
1,331 citations
Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival
Clinical Cancer Research
2006
1,042 citations
Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer
Clinical Cancer Research
2006
787 citations
Recommendations from an International Consensus Conference on the Current Status and Future of Neoadjuvant Systemic Therapy in Primary Breast Cancer
Annals of Surgical Oncology
2011
494 citations
The Landscape of Targeted Therapies in TNBC
Cancers
2020
434 citations
Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings
Breast Cancer Research and Treatment
2007
321 citations
Massimo Cristofanilli · Scinovex
